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Abstract
Background: Performance of patients immediately after anaesthesia is an area of special interest and so a clinical trial 
was conducted to compare Xenon with Isoflurane anaesthesia. In order to assess the early cognitive recovery the 
syndrome short test (SST) according to Erzigkeit (Geromed GmbH) was applied.
Methods: ASA I and II patients undergoing long and short surgical interventions were randomised to receive either 
general anaesthesia with Xenon or Isoflurane. The primary endpoint was the validated SST which covering memory 
disturbances and attentiveness. The test was used on the day prior to intervention, one and three hours post 
extubation. The secondary endpoint was the recovery index (RI) measured after the end of the inhalation of Xenon or 
Isoflurane. In addition the Aldrete score was evaluated up to 180 min. On the first post-operative day the patients rated 
the quality of the anaesthetic using a scoring system from 1-6.
Results: The demographics of the groups were similar. The sum score of the SST delivered a clear trend one hour post 
extubation and a statistically significant superiority for Xenon three hours post extubation (p < 0.01). The RI likewise 
revealed a statistically significant superiority of Xenon 5 minutes post extubation (p < 0.01). The Aldrete score was 
significantly higher for 45 min. The scoring system results were also better after Xenon anaesthesia (p < 0.001).
Conclusions: The results show that recovery from anaesthesia and the early return of post-operative cognitive 
functions are significantly better after Xenon anaesthesia compared to Isoflurane. The results of the RI for Xenon are 
similar with the previously published results.
Trial Registration: The trial was registered with the number ISRCTN01110844 http://www.controlled-trials.com/isrctn/
pf/01110844.
Background
In recent years several clinical trials have been published
that characterize the anaesthetic properties as well as the
other potential properties of Xenon [1-4]. Following the
licensing of Xenon in 12 European countries in 2007 after
Germany was first in 2005 there is increasing interest in
gaining a better understanding of the underlying scien-
tific opportunities that Xenon offers as well as the role
that Xenon can play in anaesthesia in the future.
In 1951 Cullen [5] performed an inhalational anaesthe-
sia with Xenon in old patients and showed excellence
results regarding recovery and memory. There is a lack of
data pertaining to healthy patients and recovery of post-
operative cognitive functions such as attentiveness and
memory particularly with regard to recovery on the day
of surgery following use of Xenon anaesthesia versus
standard inhalational anaesthesia. To demonstrate an
advantage of Xenon on emergence from anaesthesia and
early post-operative recovery of cognitive functions
assessed as attentiveness and memory an appropriate
method is necessary. The syndrome short test (hence-
forth referred to as SST) according to Erzigkeit (Geromed
GmbH) has proven to be reliable for more than 15 years,
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it is suitable for use in the first hours after extubation,
easy to handle, easy to use repeatedly and to replicate [6-
11] The aim of this study was to investigate the emer-
gence from inhalational anaesthesia using either Xenon
or Isoflurane until extubation time; and subsequently to
evaluate early recovery of attentiveness and memory
using the SST.
Methods
This was a prospective, randomised phase III clinical
trial, single blind with two parallel groups. The study pro-
tocol was approved by the ethics committee of the Uni-
versity Witten/Herdecke (session nr. 23/2002 of
11.09.2002; patient insurance by Winterthur Interna-
tional Nr. DE 00020283-LI-02A-715) and prior to inclu-
sion patients had to give their written consent.
Hypotheses
The aim of the study was to evaluate the efficacy of two
balanced anaesthetic regimens with respect to recovery
of early post-operative cognitive function at the day of
operation (assessed as attentiveness and memory; this
was the primary criterion) and emergence profile
(assessed as the recovery index; this was the secondary
criterion). The hypothesis was primarily that patients
have a significantly higher status of attentiveness and
memory 1 and 3 hours after inhalation anaesthesia with
Xenon compared to Isoflurane anaesthesia, and that
patients reach their pre-operative level of cognitive func-
tion within 3 hours after extubation. The second hypoth-
eses was, that the time to wake up from the anaesthetic
was predicted to be shorter following Xenon than follow-
ing Isoflurane.
Test instruments Syndrome Short Test (SST) and Recovery 
Index (RI)
The SST was provided by Geromed GmbH (address -
Cadolzburgerstr, 6, D-91074 Herzogenaurach, Germany)
and consists of nine subtests - 1 naming objects, 2 the
immediate reproduction of objects, 3 reading numbers, 4
sorting numbers, 5 counting backwards, 6 counting sym-
bols, 7 an interference test, 8 reproduce objects and 9 rec-
ognising objects. Each subtest can take up to 60 seconds.
Subtests 2, 8 & 9 evaluate memory and subtests 1, 3, 4, 5,
6 & 7 evaluate attentiveness. The time taken to run the
tests and the number of mistakes made in the subtests
were documented on an interpretation sheet; points were
allocated adjusted for age and sex. In the case of a homo-
geneous distribution of the number of points in the two
subtests, i.e., memory (subtests 2, 8, 9) and attentiveness
(subtests 1, 3, 4, 5, 6, 7) the sum score can be used to
describe the result; if the distribution is not homoge-
neous then the sum score of the subtests for memory and
attentiveness have to be used. To carry out tests for
homogeneous or non homogeneous distribution of the
results a special graphic sheet was developed by Erzigkeit
[10]. The test system is suitable for repetition and held in
the hospital in two different versions to avoid familiarisa-
tion. Within the frame of this study the baseline results
were taken pre-operatively (on the day before operation)
and post-operatively at 60 and 180 minutes post extuba-
tion. The investigator measuring the SST pre- and post-
operatively was a medical assistant and was blinded for
the inhalational anaesthetic utilized.
While the early post-operative cognitive recovery was
evaluated by means of the SST the recovery profile of
anaesthesia with respect to time until extubation and
general function was evaluated by the validated recovery
index[12]. The recovery index (RI) is defined as a bal-
anced ratio between the Aldrete score [13] measured 5
minutes post extubation plus 1 divided by the weighed
extubation time (+2) and the elapsed time until opening
eyes (+1), both measurements beginning at the end of
anaesthesia and withdrawal of the anaesthetics. Three of
the doctors in the department were responsible for con-
ducting the anaesthesia and were also responsible for
measuring eye opening, extubation time and all other
intra-operative data.
Patients
Healthy ASA I and II patients over 18 years of age sched-
uled for four different types of elective surgery were eligi-
ble. The types of surgery were: visceral surgical
strumectomy, augmentation or reduction mammaplasty,
liposuction in obese patients and knee arthroscopy.
P a t i e n t s  w e r e  r a n d o m i s e d  i n  v a r i a b l e  b l o c k s  o f  4 - 8
patients in order to balance the groups using simple self-
programmed software. The varying size of blocks was to
counteract the differing frequencies of the operations and
also any influence of duration and invasiveness of the
operations. A total of 61 patients who met the pre-
defined inclusion and exclusion criteria were randomised
either to receive Xenon in oxygen (Xenon group, n = 31)
or Isoflurane in stickoxydul (Isoflurane group (n = 30). A
power analysis was calculated for 30 patients in each
group to show a difference of one SD with a probability of
96% and a difference of 0.75 SD with a probability of 82%
(alpha = 0.05).
Anaesthesia
No premedication was administered prior to induction.
All patients were monitored with ECG leads, repeated
non invasive blood pressure measurement and oxygen
saturations. In both groups induction was accomplished
by intravenous injection of 1-2 mg/kg bodyweight (bw)
Propofol, 0.003 mg/kgbw Fentanyl and 0.6 mg/kgbw
Rocuronium Bromide, to facilitate intubation. Patients in
the liposuction group additionally had tumescence withStuttmann et al. BMC Anesthesiology 2010, 10:5
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adrenalin with a concentration of 0,66 mg/1000 ml and a
volume of 1-2 litres dependent on the field of surgery. In
the induction room and also for the first time in the oper-
ating room the maintenance of anaesthesia was achieved
with continuously infused Propofol and, if necessary, by
repeated increments of Fentanyl (0.0015 mg/kgbw).
Rocuronium Bromide was not repeated during the opera-
tion.
In the operating room the Physioflex ventilator (closed
system) with the Xenon option was used (Dräger Com-
pany, Germany). All patients were volume-controlled (7
ml/kgbw) and time-circled ventilated with identical ven-
tilation settings on a closed system until extubation with-
out spontaneous breathing. The target concentration of
end-tidal CO2 was adjusted to 35 mmHg. After reaching
a target concentration for oxygen of 98%-100% the oxy-
gen concentration was lowered to 30% in both groups to
start the administration of either Xenon or Isoflurane in
N2O (end-tidal concentration 63-65%). Normally at this
point the surgeons prepared the surgical site by disinfec-
tion meaning that all patients were in a stable steady state
of anaesthesia at incision and during any surgical stimula-
tion.
In the case that during anaesthesia the systolic BP
dropped below 100 mmHg for more than5 minutes the
patients recieved Akrinor® (a mixture of Cafedrin and
Theoadrenalin) on demand.
In the Xenon group, Xenon was flushed in by repeated
use of the flush button to reach the end-tidal target con-
centration of approximately 63% within a span of several
minutes; the Propofol infusion was then stopped. If the
Xenon concentration fell below 58% during operation
then the flush button was repeatedly used to augment
Xenon concentration in the gas mixture until a Xenon
concentration of 60% or more was achieved again. The
procedure in the Isoflurane group was identical - the
inspired oxygen concentration of 98-100% was lowered to
30% and N2O was also flushed in to lower the MAC.
Simultaneously Isoflurane was given to each patient with
an end-tidal concentration of 0.6 vol%. The Propofol
infusion was also stopped at this point. If signs occur that
the patient was too lightly anaesthetised despite a suffi-
cient inspiratory concentration of Xenon or Isoflurane,
Fentanyl was administered in increments of 0.003 mg/
kgbw to deepen anaesthesia. Depth of anaesthesia was
recorded with the bispectral index monitoring system
(BIS, software 2.21; Aspect Corporation). The BIS index
is widely used to monitor the depth of anaesthesia [14]. A
BIS value of 40 ± 10 was accepted as sufficient in both
groups. Additional application of Fentanyl increments
was only orientated by clinical signs of too light anaesthe-
sia and independent of the index number indicated by the
BIS monitor as the BIS monitor is not validated for use
with Xenon. As expected the duration of anaesthesia in
the present study differed with the different surgical
interventions however, a balanced number of cases per
type of intervention by randomisation in blocks helped to
reduce this influence.
At the end of operation with all surgical interventions
finished the Isoflurane vaporizer was set to zero vol% and
simultaneously the breathing system flushed with oxygen
to eliminate both inhalational anaesthetics. In the Xenon
group the breathing system was also flushed with oxygen
to eliminate Xenon at the same point. The time at which
this occurred was taken in both groups to be the end of
anaesthesia. The patients were asked every minute to
open their eyes and to follow commands. Extubation was
performed at the time of eye opening provided that there
was spontaneous breathing and that the patient was oth-
erwise stable. Eye opening time and extubation time were
noted. Five minutes post extubation the Aldrete score
was evaluated for the first time. Further evaluation of the
Aldrete score was performed at 15, 30, 45, 60, 90, 120 and
180 minutes post extubation to measure general perfor-
mance. On the first post-operative day all patients were
visited by the person measuring the SST and asked to
judge the quality of anaesthesia by using a simple scoring
system - a numerical value between 1 and 6 with 1 for
poor and 6 for excellent.
Additional documented parameters covered blood
pressure, heart rate, oxygen saturation and laboratory
data as necessary. Different times of anaesthesia, the
Xenon or Isoflurane inhalation time, the incision to
suture time and the time of cessation of anaesthesia
(flushing the breathing system of the Physioflex apparatus
with oxygen) were documented.
The most common side effect of anaesthesia in the
recovery room PONV was documented and treated with
metoclopramide, dimenhydrinate and dolasetrone if nec-
essary.
In the recovery room the patients received piritramide
and metamizole on demand for pain relief.
Statistical Analysis
Statistical analysis was performed with the Sigma Stat
package (Systat software, Inc. version 3.5) after data entry
and verification thereof. Sigma Plot (version 9.0) was
used for graphical presentations.
Quantitative data were summarized by descriptive sta-
tistics - valid numbers, arithmetic means, medians, stan-
dard deviation, standard error, confidence intervals and
box plots. Besides this, the nominal and ordinal scale data
was presented as frequencies and corresponding percent-
ages.
Two Way Analyses of Variance were used in the case of
normal distributions. In case of abnormal distributions
appropriate non-parametric tests were used. Taking scaleStuttmann et al. BMC Anesthesiology 2010, 10:5
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levels into account possible inter group differences were
evaluated with the Wilcoxon-Mann-Whitney-U-Test,
Wilcoxon-Pratt test and the Mantel-Haenszel Test. Val-
ues of p < 0.05 (α = 5%: How to reject the hypothesis of no
difference) were considered as statistically significant.
The primary endpoint only (SST: 3 hours post interven-
tion) was interpreted as confirmatory. The sum test result
of the SST had to be proven for homogeneity. In case of
non homogeneous distribution between the subtests for
memory and attention the summarized sub tests were
compared between each group.
Results
Key demographic data of the patients are described in
Table 1 - as shown in this table both groups were compa-
rable. Due to low patient numbers in the subgroups a
consolidation of the data divided into clinical indications
was indicated for statistical calculations. The conduction
of anaesthesia was uneventful in both groups. The circu-
latory parameters and the BIS value are only evaluated
during operation and reflect the time of Xenon insuffla-
tions. The circulatory data showed the advantages of the
Xenon anaesthesia with a lower heart rate and a higher
mean arterial pressure (MAP). The systolic and diastolic
pressures were also higher in the Xenon group. The BIS
value was always within the desired level and nearly iden-
tical in both groups except that after the start of Xenon
insufflations the BIS level was slightly lower in the Xenon
group for only ten minutes - it is unlikely that this differ-
ence has influenced the wake up time. Indeed the circula-
tory data and the BIS level are interpreted as a stable
depth of anaesthesia and no patient reported awareness
on the visit one day post-operatively.
Regarding the drug consumption during surgery, addi-
tional medication in the recovery room and for pain relief
we refer to Table 2. PONV occurs in 13 patients in the
Xenon group and in 8 patients in the Isoflurane group.
One patient in the Isoflurane group received Akrinor® due
to low blood pressure.
Recovery Index
In accordance with the previous findings the results of
the post-operative RI demonstrated a clear superiority of
Xenon in comparison with Isoflurane (Xenon: RI 1.0 SD
0.6; CI95: 0.8-1.2; Isoflurane: RI 0.3 SD 0.1; CI95: 0.2-0.4)
which was confirmed by a statistical significant and clini-
cally relevant difference (P < 0.01). These results are visu-
alized in Figure 1 and all the data used to calculate the RI
is in Table 3.
Syndrome short test
An SST with a sum score of 0-2 points is representative
for healthy people without any disturbance of cognitive
function; a test result of 3-4 points indicates suspicion of
cognitive dysfunction; 5-8 points suggests light cognitive
dysfunction and 9-13 points suggests the beginning of a
psycho-organic syndrome. The results of the pre-opera-
tive measurement of the SST were normal and compara-
ble in both groups with a mean of 1.5 points (CI: 0.8-2.2
points) in the Xenon group and 1.7 points (CI: 1.0-2.4
points) in the Isoflurane group. Post-operatively, the
results of the SST suggested a superiority of Xenon in
comparison with Isoflurane with the 1-hour results
showing an apparent advantage of Xenon; this, however,
could not be verified from a statistical point of view
(Xenon SST after 1 h: 6.8 points; CI95: 5.2-8.4 points; Iso-
Table 1: Demographic data: Xenon and Isoflurane anaesthesia.
Xenon Isoflurane
n3 1 3 0
Age [years] 41,5 (CI95: 36.4, 46.7) 38.9 (CI95: 34.0. 43.8)
Gender [m/f] 8/23 6/24
ASA class
I 10/(32.3%) 7/(23.3%)
II 21/(67.7%) 23/(76.7%)
Height [cm] 166.9 (CI95: 164.4, .69.4) 169.4 (CI95: 166.0. 70.2)
Body weight [kg] 68.2 (CI95: 63.8, 72.6) 71.2 (CI95: 66.2, 76.3)
Surgical intervention/incision to suture time (minutes)
Visceral strumectomy [n] 9/124.9 SD 28.1 9/102.7 SD 27.8
Knee arthroscopy [n] 7/74.7 SD 56.2 7/105.0 SD 68.2
Liposuction [n] 8/194.9 SD 83 8/199.1 SD 33.5
Mammaplasty [n] 7/119.1 SD 27 6/129.7 SD 68.2Stuttmann et al. BMC Anesthesiology 2010, 10:5
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flurane SST after 1 h: 8.3 points; CI95: 7.0-9.6 points).
These results and the clinical condition at 1 hour suggest
light cognitive dysfunction. After 3 hours the results of
the SST were continuously better in both groups and rep-
resentative for healthy people without disturbance of cog-
nitive function in the xenon group and the suspicion of
cognitive dysfunction after Isoflurane. The difference was
statistically significant in favour of Xenon (Xenon SST
after 3 h: 2.1 points; CI95: 1.4-2.8 points; Isoflurane SST
after 3 h: 3.8 points; CI95: 2.8-4.8 points) (P < 0.001).
The differentiation into the two subtests of the SST
(memory and attentiveness) showed an expected deterio-
ration in both groups between the pre-operative situation
and the one-hour post extubation control. The three-
hour post extubation results indicated an obvious trend
to the pre-operative level in both groups in favour of
Xenon. Neither the difference in the number of points in
the subtests of memory nor in the subtests of attentive-
ness could reach statistical significance in any group (α =
0.05). At time spans of 1 and 3 hours, 7 patients revealed
heavy or very heavy disturbance of memory in the Isoflu-
rane group compared to only 2 patients in the Xenon
group (not significant). At the same times the tests of dis-
turbance of attention showed no difference in the number
of patients with light and mean deteriorations (11
patients after Xenon and 13 patients after Isoflurane).
These results are summarized in Table 4.
Aldrete score
Post-operative the Aldrete score demonstrated a signifi-
cant advantage in the Xenon group for 45 minutes and a
positive trend for 60 minutes (Figure 2). Compared to the
Isoflurane group in the Xenon group the maximum was
reached earlier. Only liposuction patients with long inci-
sion to suture time showed no difference. Simple scoring
system to assess the quality of anaesthesia by the patients
post-operatively in the Xenon group were significantly
better; i.e., mark 5 = very good. The corresponding mark
in the Isoflurane group was 4 (P < 0.0005).
Discussion
In hospital bedside care is facilitated on those patients
who have a high level of both independence and coopera-
tion.
The results of this clinical trial are focused firstly on the
comparison of both patient groups with the SST. Sec-
ondly, the RI quotient using eye opening time, extubation
time and Aldrete score was calculated. Both criteria are
considered to be valuable tools to make an assessment of
the recovery from anaesthesia during the first hours.
While the RI provides information about the waking time
directly after the end of anaesthesia, the SST generates
very important information about parameters of cogni-
tive function. The SST was measured at 1 and 3 hours
post extubation to evaluate the early post extubation
phase in healthy patients without any risk to develop cog-
nitive dysfunction after anaesthesia and surgery. With
these instruments the description of Cullen and the rela-
tion between the speed of recovery after the end of anaes-
thesia (RI) and the cognitive performance (SST) the first
3 hours there after has been proven.
Table 2: Comparison regarding Drug consumption in both groups.
Drug Xenon Isoflurane
Propofol total consumption 219.5 mg (SD 54.49) n = 31 190 mg (SD 42) n = 30
Fentanyl for induction 0.273 mg (SD0.05) n = 31 0.286 mg (SD 0,048) n = 30
Fentanyl consumption during surgical procedure 0.46 mg (SD 0.23) n = 31 0.216 mg (SD 0.17) n = 30
Rocuronium total consumption 39.4 mg (SD 7,5) n = 31 40.6 mg (SD 8.6) n = 30
Piritramide 5.9 mg (SD3.2) n = 7 7.8 mg (SD 2.7) n = 14
Metamizole 1 g n = 1 0
Dimenhydrinate 82.7 mg (SD 35.8) n = 3 31 mg n = 1
Metoclopramide 10 mg (SD 0) n = 12 13.7 mg (SD 5) n = 6
Dolasetrone 13.9 mg (SD 4.2) n = 9 10.8 mg (SD2.9) n = 3Stuttmann et al. BMC Anesthesiology 2010, 10:5
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In a review article Guinta [15] described the anaes-
thetic and pharmacologic properties of the NMDA recep-
tor antagonist Xenon and N2O. Xenon has a blood-gas
distribution coefficient of 0.14 and Isoflurane a higher
blood-gas distribution coefficient of 1.41. Xenon has an
oil-gas distribution coefficient of 1.9 and Isoflurane a
much higher oil-gas distribution coefficient of 98. The
oil-gas distribution coefficient (or fat solubility) deter-
mines the effectiveness of narcotic gases and influences
the kinetics of distribution in the body. The oil-gas distri-
bution coefficient of Xenon is associated with a better
solubility in oil as compared with blood by a factor of 14
and for Isoflurane by a factor of 86. The smaller the factor
the faster is the wake up time from anaesthesia. Accord-
ing to these data and the expected difference in the wake
up time and the recovery of attentiveness and memory
the sample size was calculated to be adequate to show a
difference in the SST, when Xenon is compared to Isoflu-
rane. Isoflurane is a widespread used inhalation anaes-
thetic and ideal for totally closed systems because the
accumulation of potentially toxic compounds is
unknown.
The minimal alveolar concentration (MAC) of Xenon
was first described to be 0.71 (= 71%) [16]. More recently
performed investigations corrected the MAC-value to
63%[17]. Following the SPC in Europe inhalation anaes-
thesia with Xenon has to be combined with an opioid.
The target concentrations of Xenon of about 63% (MAC
1.0) and the combination with Fentanyl were in accor-
dance with those recommendations. Isoflurane anaesthe-
sia was combined with the NMDA receptor antagonist
N2O as the porter gas to  mimic the NMDA receptor
antagonist Xenon and to lower the MAC and also supple-
mented with increments of Fentanyl. The depth of anaes-
thesia was measured by means of the BIS. The BIS
monitor is empirically validated for anaesthetics drugs
acting on the GABA receptor and was not yet validated
for NMDA receptor antagonists like Xenon during the
study periode. Thus, the depth of anaesthesia was con-
trolled in both groups only by clinical signs. According to
Goto [18], the BIS monitoring was also not used for the
waking period because in patients waking up from Xenon
anaesthesia the time to react to verbal commands can not
be predicted by the BIS level. An influence on recovery by
the invasiveness, frequency and duration of the interven-
tion was excluded by a block randomisation.
The "recovery index" is deemed to be validated with
data from the literature[19,20] The expressiveness of this
index was verified in two large randomised clinical trials.
A difference of the RI of 0.17 is classified as clinically rele-
vant. In the investigation presented here the difference
was 0.7 and therefore even distinctly more pronounced as
shown in an arrangement of Xenon and Sufentanil being
0.3 [21]. All individual parameters shown in Table 3 as
Figure 1 Mean Recovery Index.
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Table 3: Eyes opening time, extubation time and Aldrete score after 5 min.
Group All strumectomy mammaplasty liposuction arthroscopy
Xenon (eyes opening time)
N3 1 9787
Mean 4,0 4,0 4,1 4,8 2,9
SD 2,0 2,2 1,6 2,3 1,6
CI 3,3 -- 4,7 2,3 -- 5,7 2,6 -- 5,6 2,9 -- 6,7 1,4 -- 4,4
Isoflurane (eyes opening time)
N3 0 9687
Mean 8,9 8,1 11,7 9,1 7,1
SD 3,5 2,9 4,3 3,9 2,0
CI 7,6 -- 10.2 5,9 -- 10.3 7,2 -- 16,2 5,8 -- 12,4 5,3 -- 8,9
Xenon (extubation time)
N3 1 9787
Mean 4,5 4,2 4,7 5,5 3,3
SD 2,2 2,4 1,1 2,8 1,9
CI 3,7 -- 5,3 2,4 -- 6,0 3,7 -- 5,7 3,1 -- 7,9 1,6 -- 5,0
Isoflurane (extubation time)
N3 0 9687
Mean 10.2 9,6 12,8 10.0 9,0
SD 3,5 2,7 4,4 4,2 2,2
CI 8,9 -- 11,5 7,5 -- 11,7 8,2 -- 17,4 6,5 -- 13,5 7,0 -- 11,0
Xenon (Aldrete score, 5 minutes post extubation)
N3 1 9787
Mean 8,8 8,4 9,6 7,9 9,7
SD 1,1 0.5 0.5 1,4 0.8
CI 8,4 -- 9,2 8,0 - 8,8 9,1 -- 10.1 6,8 - 9,0 9,0 -- 10.4Stuttmann et al. BMC Anesthesiology 2010, 10:5
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well as the index itself were significantly superior for
Xenon as compared to the comparator Isoflurane.
The SST system was primary developed to test memory
and attentiveness in elderly patients to detect dementia
[22]; later on the test system was also used to describe the
conditions of recovery after anaesthesia [23,24]. The use
of the SST as the best suitable test system was carefully
selected between other test systems in this study to inves-
tigate the early cognitive recovery, especially memory and
attentiveness after general anaesthesia at the day of the
operation [11,25,26]. Pre-operatively the mean value of
the sum score of the SST was normal and within the same
range in both groups. One hour post extubation, the
patients showed a light disturbance of cognitive function
as indicated by the sum score but there was a trend in
favour of Xenon. No difference between the groups was
observed in the sub-score for attention. In the sub-score
for memory in the Isoflurane group 7 patients had heavy
o r  v e r y  h e a v y  d i s t u r b a n c e  o f  m e m o r y  a n d  o n l y  t w o
patients in the Xenon group. After 3 hours the SST sum
score was significantly better in the Xenon group and
approximately the same compared to the pre-operative
situation. At the same point in time the SST sum score in
the Isoflurane group, was still in a range with suspicion of
disturbance of cognitive functions. This is the first con-
trolled randomised clinical trial showing a significant
advantage of Xenon anaesthesia on the recovery profile of
mental functions with an appropriate test instrument.
Regarding the clinical daily life, the fast recovery after a
Xenon anaesthesia reflects a good and normal response
of the patient and a good restoration of memory equiva-
lent to the pre-operative level already three hours after
extubation.
Different clinical trials which investigate how patients
recover and wake from Xenon anaesthesia especially the
first 3 hours post extubation are not available. In a study
by Coburn et al[27] the post-operative recovery of cogni-
tive function was investigated in elderly patients 65-75
years old without or at a low risk to develop psycho-cog-
nitive dysfunction post-operatively anaesthetized with
either Xenon or Desflurane. As a test entity, the test for
performance of attention with a subtest of alertness,
dividing attention and working memory was used (TAP-
test). The tests were performed pre-operatively and 6-12
hours as well as 66-72 hours post-operatively. The tests
were performed at the highest difficulty level. At all
points in time the result of the TAP-test did not show any
statistically significant change between the groups, nei-
ther pre-operatively nor post-operatively. Recently, the
incidence of psycho-cognitive dysfunction after Xenon or
Propofol anaesthesia was also investigated in elderly
patients (65-83 years old) by Höcker et al. [28]. In his
study the test battery used was based on the neurophysio-
logical tests performed in the "International Studies of
Post-Operative Cognitive Dysfunction (POCD) 1 and 2"
[29,30]. The tests were realized as baseline 1 day before
and subsequently 1 day, 6 days and 30 days after surgery.
The incidence of POCD after Xenon or Propofol anaes-
thesia was only slightly reduced in the Xenon group as a
trend at all days post-operatively. The investigation of the
incidence of POCD after Xenon or Isoflurane anaesthesia
in patients at risk was not the aim of our study. In the
present study young and healthy patients were investi-
gated to prove the recovery of memory and attentiveness
the first hours following extubation.
No investigations are available as to which one of the
following tests are better to cover the early post-operative
recovery and which time point is the best to test: The
TAP-test, the SST, or f. e. the Mini Mental-test [31]. In
the present investigation the SST was used in accordance
with Erzigkeit in order to determine the outcome of the
variable "cognitive productive efficiency". A more inten-
sive and longer test like the TAP-tests partly shows the
extent of mental fatigue over time. In the early post-oper-
ative phase mental fatigue after extensive interventions
may be due to somatic reasons. With standardization and
measuring time to run exercises and registering the num-
ber of mistakes by remembering symbols in the authors'
opinion the SST is especially appropriate to evaluate the
early post-operative course of the cognitive productive
efficiency. The individual intelligence quotient of the
patients is incorporated in the test system. This is of
Isoflurane (Aldrete score, 5 minutes post extubation)
N3 0 9687
Mean 7,3 6,9 7,5 7,5 7,6
SD 1,2 1,5 1,2 1,4 0.8
CI 6,8 - 7,8 5,8 -- 8,0 6,2 -- 8,8 6,3 -- 8,7 6,9 -- 8,3
Xenon versus Isoflurane anaesthesia (Mean, SD, CI).
Table 3: Eyes opening time, extubation time and Aldrete score after 5 min. (Continued)Stuttmann et al. BMC Anesthesiology 2010, 10:5
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advantage when compared with the TAP-test. The inter-
pretation of the procedure allows for a statement about
the severity of a post-operatively measured disturbance of
memory or attentiveness[32,33]. The difference of the
blood-gas partition coefficient of the inhalational anaes-
thetics investigated by Coburn is considerably smaller as
compared to the present study. Therefore, the expected
difference in the speed of recovery after the end of anaes-
thesia with either Xenon or Desflurane must be smaller
in his study. The first test evaluation post-operatively
shows the same result at baseline level and already com-
plete recovery in both groups after 6-12 hours. In the set-
ting of Coburn the time span between extubation and the
first measurement of cognitive recovery was too long to
expect any difference. In the authors opinion the first
testing time was simply too late to discriminate the
groups. This fact seems to be more important than the
test systems used.
The Aldrete score showed an advantage of Xenon over
45 minutes post extubation. In many cases this time is
corresponding to the resting time in the recovery room
and may be a further advantage of the Xenon anaesthesia.
This was not observed and measured in long and invasive
operations like high volume liposuction.
There are some limiting facts of this study. Depending
on the kind of surgery and the early post-operative course
of treatment the optimal condition that the patient has to
have is not defined. It remains unclear if a higher state of
attentiveness and better memory of the patients already a
few hours post extubation are a real advantage for sta-
tionary patients and have any influence on treatment and
costs. The resting time in the recovery room, only depen-
dent on the medical condition of the patients was not
measured and the effort for care of the staff in the recov-
ery unit and thereafter on the ward was not investigated.
Table 4: Subscores of memory and attentiveness at three time points.
Disturbance of memory
Points 0--1 2--3 4--5 6--7 8--9
No Light mean Heavy very heavy
time Xe/iso xe/iso xe/iso xe/iso xe/iso Σ
Pre 28/28 1/2 2/0 0 0 31/30
1 h 9/13 9/3 11/9 2/4 0/1 31/30
3 h 24/21 7/4 0/3 0/2 0/0 31/30
Disturbance of attention
Points 0--2 3--5 6--9 10--12 13--15
No very light light mean heavy
time xe/iso xe/iso xe/iso xe/iso xe/iso Σ
Pre 26/24 5/5 2/1 0/0 0/0 31/30
1 h 7/8 12/12 9/7 3/3 0/0 31/30
3 h 24/19 5/8 2/3 0/0 0/0 31/30
Preoperatively (pre) after 1 and 3 hours. Xenon versus Isoflurane anaesthesia (xe/iso).Stuttmann et al. BMC Anesthesiology 2010, 10:5
http://www.biomedcentral.com/1471-2253/10/5
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Conclusion
In summary it has been shown that the wake-up time
after anaesthesia with Xenon is faster compared to Isoflu-
rane in N2O. Overall, it is concluded that in the referred
study the differences between the Xenon and Isoflurane
group in the RI, the SST sum score, the sub-scores for
memory and attentiveness and the Aldrete score are clin-
ically relevant for the treatment directly after the extuba-
tion, the resting time in the recovery room and on the
normal ward directly thereafter. A better memory and a
higher state of attentiveness may help to facilitate early
post-operative care and improve cooperation and compli-
ance of the patients at the day of operation. A relation
between the speed of recovery (RI) and the early post-
operative cognitive function as the improvement of the
SST was shown after Xenon anaesthesia. Further studies
will have to elucidate that Xenon anaesthesia combined
with other short acting drugs may have an advantage on
general outcome post-operatively not only in healthy
patients but especially in elderly patients being at risk
developing cognitive dysfunction after anaesthesia and
surgery.
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